Move over personalized supplements and multivitamins, ditch the protein powder, and wave bye-bye to your skincare routine. It ...
Novo Nordisk (NVO +1.78%), which develops and markets diabetes and obesity treatments, closed Tuesday’s session at $51.61, up 7.30% after U.S. approval of its once-daily oral Wegovy weight-loss pill.
Here’s what we’re covering: Angering Denmark, Trump Appoints Special Envoy to Greenland by Amelia Nierenberg, Jeffrey Gettleman and Maya Tekeli Trump Administration Orders Nearly 30 U.S. Ambassadors ...
Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...
NEW DELHI: Scientists from IIT Delhi and AIIMS New Delhi have successfully tested a swallowable “smart pill” that can collect microbiome samples directly from inside the intestine, a breakthrough that ...
CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise. The new, large language model-fueled version of Alexa is ...